Tech Company Financing Transactions
Nuclein Funding Round
On 4/3/2021, Nuclein landed $14 million in Series B investment from Trinity Private Equity Group and private investors.
Transaction Overview
Company Name
Announced On
4/3/2021
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series B
Investors
Trinity Private Equity Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds to to commercialize its novel, hand-held PCR platform designed as a disposable, all-in-one, self-test for infectious disease diagnosis.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
7301 N. Fm 620 Rd. 155-113
Austin, TX 78730
USA
Austin, TX 78730
USA
Phone
Website
Email Address
Not Recorded
Overview
Nuclein, LLC was founded in 2017 by long-time Austin biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The company's vision is to enable simple, affordable, rapid, and accurate disease testing for everyone.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alan Blake
President
Richard Crockett
Browse more venture capital transactions:
Prev: 4/3/2021: Curri venture capital transaction
Next: 4/5/2021: Cyble venture capital transaction
Share this article
Where The Data Comes From
We document funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs